The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study: Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756
Related Posts
Krishnareddigari M, Joodi G, Zinoviev RI, Yarra S, Aksoy O. Improved hemodynamic performance and reduced paravalvular regurgitation with the SAPIEN 3 Ultra RESILIA valve: a[...]
Roman S, Budoff MJ. Effect of Omega-3 fatty acids, fibrates and PCSK9 inhibitors on atherosclerotic plaque burden, composition and stability: Insights from imaging. Pharmacol Ther.[...]
Hsu YC, Lu M, Llanes A, Keushkerian MJ, Nguyen KL, Johnson K, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner D, McNally[...]